• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAnaptysBio
    Picture of AnaptysBio logo

    ANAB — AnaptysBio News Story

    $46.450.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    • Market Cap
      $1.39bn
    • Enterprise Value
      $1.48bn
    • Revenue
      $53.04m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ANAB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ANAB Dividends
    All News

    NASDAQ RESUMED AT 11:34 AM

    Picture of AnaptysBio logoAnaptysBio
    06/04/2026 16:34
    NASDAQ RESUMED  ANABV.O  AT 11:34 AM
    

    Recent news on AnaptysBio

    See all news
    • First Tracks Biotherapeutics up after $200 mln equity raise

      15/10/2026 13:33
    • US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB

      30/09/2026 08:35
    • US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals

      23/09/2026 08:36
    • Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update

      21/09/2026 23:10
    • AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties

      21/09/2026 21:26

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.